SLAB — Silicon Laboratories Income Statement
0.000.00%
Last trade - 00:00- $6.76bn
- $6.32bn
- $784.76m
- 82
- 15
- 91
- 68
Annual income statement for Silicon Laboratories, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,024 | 721 | 782 | 584 | 785 |
| Cost of Revenue | |||||
| Gross Profit | 643 | 425 | 461 | 312 | 457 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 905 | 757 | 806 | 750 | 855 |
| Operating Profit | 119 | -36.2 | -24.2 | -165 | -70.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 126 | -58.2 | -10.5 | -155 | -57.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 88 | -71.6 | -18.5 | -191 | -64.9 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 91.4 | 2,117 | -34.5 | -191 | -64.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 91.4 | 2,117 | -34.5 | -191 | -64.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.61 | -1.3 | -1.09 | -5.73 | -1.98 |